128 related articles for article (PubMed ID: 36412216)
1. Risks of malignancies among patients with psoriasis: A cohort study of 360 patients.
Watanabe T; Watanabe Y; Asai C; Asami M; Watanabe Y; Saigusa Y; Yamaguchi Y
J Dermatol; 2023 May; 50(5):615-621. PubMed ID: 36412216
[TBL] [Abstract][Full Text] [Related]
2. Malignancy in psoriatic disease: Results from prospective longitudinal cohorts.
Polachek A; Muntyanu A; Lee KA; Ye JY; Chandran V; Cook RJ; Gladman DD
Semin Arthritis Rheum; 2021 Feb; 51(1):144-149. PubMed ID: 33383290
[TBL] [Abstract][Full Text] [Related]
3. Risk of malignancies in psoriasis patients treated with cyclosporine: a 5 y cohort study.
Paul CF; Ho VC; McGeown C; Christophers E; Schmidtmann B; Guillaume JC; Lamarque V; Dubertret L
J Invest Dermatol; 2003 Feb; 120(2):211-6. PubMed ID: 12542524
[TBL] [Abstract][Full Text] [Related]
4. Cancer risk in 892 089 patients with psoriasis in Korea: A nationwide population-based cohort study.
Lee JH; Kim HJ; Han KD; Kim HN; Park YM; Lee JY; Park YG; Lee YB
J Dermatol; 2019 Feb; 46(2):95-102. PubMed ID: 30443930
[TBL] [Abstract][Full Text] [Related]
5. Risk of malignancy in patients with psoriasis: a 15-year nationwide population-based prospective cohort study in Korea.
Lee JW; Jung KJ; Kim TG; Lee M; Oh J; Jee SH; Lee MG
J Eur Acad Dermatol Venereol; 2019 Dec; 33(12):2296-2304. PubMed ID: 31287593
[TBL] [Abstract][Full Text] [Related]
6. Cohort study of malignancies and hospitalized infectious events in treated and untreated patients with psoriasis and a general population in the United States.
Kimball AB; Schenfeld J; Accortt NA; Anthony MS; Rothman KJ; Pariser D
Br J Dermatol; 2015 Nov; 173(5):1183-90. PubMed ID: 26265015
[TBL] [Abstract][Full Text] [Related]
7. Body surface area affected by psoriasis and the risk for psoriatic arthritis: a prospective population-based cohort study.
Ogdie A; Shin DB; Love TJ; Gelfand JM
Rheumatology (Oxford); 2022 May; 61(5):1877-1884. PubMed ID: 34508558
[TBL] [Abstract][Full Text] [Related]
8. Risk of malignancy in patients with psoriasis according to treatment modalities in Korea: a nationwide cohort study.
Hong JY; Ahn J; Won S; Kim SM; Cho YA; Kim CY; Sung JY; Yu DA; Lee YW; Choe YB
Sci Rep; 2022 Nov; 12(1):20690. PubMed ID: 36450739
[TBL] [Abstract][Full Text] [Related]
9. Malignancy incidence in patients with psoriatic arthritis: a comparison cohort-based incidence study.
Wilton KM; Crowson CS; Matteson EL
Clin Rheumatol; 2016 Oct; 35(10):2603-7. PubMed ID: 27572325
[TBL] [Abstract][Full Text] [Related]
10. The risk of malignancy associated with psoriasis.
Margolis D; Bilker W; Hennessy S; Vittorio C; Santanna J; Strom BL
Arch Dermatol; 2001 Jun; 137(6):778-83. PubMed ID: 11405770
[TBL] [Abstract][Full Text] [Related]
11. The risk of cancer in patients with psoriasis: a population-based cohort study in Taiwan.
Chen YJ; Wu CY; Chen TJ; Shen JL; Chu SY; Wang CB; Chang YT
J Am Acad Dermatol; 2011 Jul; 65(1):84-91. PubMed ID: 21458106
[TBL] [Abstract][Full Text] [Related]
12. Psoriatic patients with diabetes are prone to develop digestive organ cancers: a population-based study in Taiwan.
Lan CC; Ko YC; Yu HS; Li WC; Wu CS; Lu YW; Yang YH; Chen GS
J Dermatol Sci; 2012 Nov; 68(2):82-8. PubMed ID: 22986081
[TBL] [Abstract][Full Text] [Related]
13. Incidence rates of malignancies and hospitalized infectious events in patients with psoriasis with or without treatment and a general population in the U.S.A.: 2005-09.
Kimball AB; Schenfeld J; Accortt NA; Anthony MS; Rothman KJ; Pariser D
Br J Dermatol; 2014 Feb; 170(2):366-73. PubMed ID: 24251402
[TBL] [Abstract][Full Text] [Related]
14. Increased risk of atherosclerotic cardiovascular disease among patients with psoriasis in Korea: A 15-year nationwide population-based cohort study.
Jung KJ; Kim TG; Lee JW; Lee M; Oh J; Lee SE; Chang HJ; Jee SH; Lee MG
J Dermatol; 2019 Oct; 46(10):859-866. PubMed ID: 31432567
[TBL] [Abstract][Full Text] [Related]
15. Hypertension and risk of psoriasis incidence: An 11-year nationwide population-based cohort study.
Kim HN; Han K; Song SW; Lee JH
PLoS One; 2018; 13(8):e0202854. PubMed ID: 30142208
[TBL] [Abstract][Full Text] [Related]
16. Association between systemic antipsoriatic drugs and cardiovascular risk in patients with psoriasis with or without psoriatic arthritis: a nationwide cohort study.
Chen YJ; Chang YT; Shen JL; Chen TT; Wang CB; Chen CM; Wu CY
Arthritis Rheum; 2012 Jun; 64(6):1879-87. PubMed ID: 22161801
[TBL] [Abstract][Full Text] [Related]
17. Arthritis as an important determinant for psoriatic patients to develop severe vascular events in Taiwan: a nation-wide study.
Chin YY; Yu HS; Li WC; Ko YC; Chen GS; Wu CS; Lu YW; Yang YH; Lan CC
J Eur Acad Dermatol Venereol; 2013 Oct; 27(10):1262-8. PubMed ID: 23004680
[TBL] [Abstract][Full Text] [Related]
18. The Incidence and Risk Factors for Psoriatic Arthritis in Patients With Psoriasis: A Prospective Cohort Study.
Eder L; Haddad A; Rosen CF; Lee KA; Chandran V; Cook R; Gladman DD
Arthritis Rheumatol; 2016 Apr; 68(4):915-23. PubMed ID: 26555117
[TBL] [Abstract][Full Text] [Related]
19. The risk of malignancy among biologic-naïve pediatric psoriasis patients: A retrospective cohort study in a US claims database.
Gu Y; Nordstrom BL
J Am Acad Dermatol; 2017 Aug; 77(2):293-301.e1. PubMed ID: 28623045
[TBL] [Abstract][Full Text] [Related]
20. Psoriasis is not a risk factor for dementia: a 12-year nationwide population-based cohort study.
Wu CY; Hu HY; Chou YJ; Li CP; Chang YT
Arch Dermatol Res; 2020 Nov; 312(9):657-664. PubMed ID: 32152723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
